{"component": "definition", "props": {"groups": [{"size": 7, "snippet": "has the meaning set forth in Section 5.1.9.", "snippet_links": [], "samples": [{"hash": "hGJjKC6axkC", "uri": "/contracts/hGJjKC6axkC#interim-reports", "label": "Asset Purchase Agreement (Verizon South Inc)", "score": 18.0, "published": true}, {"hash": "dV1s2FHirQJ", "uri": "/contracts/dV1s2FHirQJ#interim-reports", "label": "Asset Purchase Agreement (Centurytel Inc)", "score": 18.0, "published": true}, {"hash": "anoS5y8MOsb", "uri": "/contracts/anoS5y8MOsb#interim-reports", "label": "Asset Purchase Agreement (Verizon South Inc)", "score": 18.0, "published": true}], "hash": "318c41c5f8d11b4ae571d6931f0b8c60", "id": 1}, {"size": 6, "snippet": "is defined in Section 4.4(a).", "snippet_links": [{"key": "defined-in-section", "type": "clause", "offset": [3, 21]}], "samples": [{"hash": "4dL2AJBhCKZ", "uri": "/contracts/4dL2AJBhCKZ#interim-reports", "label": "Asset Purchase Agreement", "score": 31.340862423, "published": true}, {"hash": "9bgoKvg7ny9", "uri": "/contracts/9bgoKvg7ny9#interim-reports", "label": "Asset Purchase Agreement (XCel Brands, Inc.)", "score": 30.1225188227, "published": true}, {"hash": "iKiGM3n49TU", "uri": "/contracts/iKiGM3n49TU#interim-reports", "label": "Asset Purchase Agreement (XCel Brands, Inc.)", "score": 25.977412731, "published": true}], "hash": "ec8d29ac610c1e9fa10171cc2198ff66", "id": 2}, {"size": 4, "snippet": "shall have the meaning given in Section 8.1.", "snippet_links": [{"key": "section-81", "type": "clause", "offset": [32, 43]}], "samples": [{"hash": "2704C9pqcVJ", "uri": "/contracts/2704C9pqcVJ#interim-reports", "label": "Research and Development Collaboration Agreement (Atara Biotherapeutics, Inc.)", "score": 33.1587953457, "published": true}, {"hash": "dd5Cc2ffCeC", "uri": "/contracts/dd5Cc2ffCeC#interim-reports", "label": "Research and Development Collaboration Agreement (Atara Biotherapeutics, Inc.)", "score": 31.855578371, "published": true}, {"hash": "kU1S9zKeEhu", "uri": "/contracts/kU1S9zKeEhu#interim-reports", "label": "Research and Development Collaboration Agreement (Atara Biotherapeutics, Inc.)", "score": 30.8480492813, "published": true}], "hash": "6be67bae6a9ed4f8719af9de2ae5ae5c", "id": 3}, {"size": 3, "snippet": "Means any additional report(s) issued by the Grantholder and the Institution following a request by Diabetes UK pursuant to clause 10.2 of the Conditions;", "snippet_links": [{"key": "issued-by", "type": "clause", "offset": [31, 40]}, {"key": "the-institution", "type": "clause", "offset": [61, 76]}, {"key": "pursuant-to-clause", "type": "clause", "offset": [112, 130]}, {"key": "the-conditions", "type": "clause", "offset": [139, 153]}], "samples": [{"hash": "kcxv1XXlBSU", "uri": "/contracts/kcxv1XXlBSU#interim-reports", "label": "Grant Agreement", "score": 31.0400558686, "published": true}, {"hash": "aLwWikUIty5", "uri": "/contracts/aLwWikUIty5#interim-reports", "label": "Grant Agreement", "score": 25.2245037645, "published": true}, {"hash": "7eKj8lpAlW", "uri": "/contracts/7eKj8lpAlW#interim-reports", "label": "Grant Agreement", "score": 24.3490759754, "published": true}], "hash": "aeedd0b49a6279e1de2ce1a81397c679", "id": 4}, {"size": 3, "snippet": "to read as follows:", "snippet_links": [], "samples": [{"hash": "gx6HR9KPmAk", "uri": "/contracts/gx6HR9KPmAk#interim-reports", "label": "Cooperative Research and Development Agreement", "score": 31.340862423, "published": true}, {"hash": "C9KI3jwFGC", "uri": "/contracts/C9KI3jwFGC#interim-reports", "label": "Cooperative Research and Development Agreement (Accentia Biopharmaceuticals Inc)", "score": 21.0, "published": true}, {"hash": "8iaaZyUcQ5B", "uri": "/contracts/8iaaZyUcQ5B#interim-reports", "label": "Cooperative Research and Development Agreement (Accentia Biopharmaceuticals Inc)", "score": 21.0, "published": true}], "hash": "461b6c858e9498c4ddef2a226c4bf09d", "id": 5}, {"size": 2, "snippet": "Steering Committee reports or copies of Annual Reports updating the [*] Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.", "snippet_links": [{"key": "steering-committee-reports", "type": "clause", "offset": [0, 26]}, {"key": "copies-of", "type": "definition", "offset": [30, 39]}, {"key": "annual-reports", "type": "definition", "offset": [40, 54]}, {"key": "information-on", "type": "clause", "offset": [80, 94]}, {"key": "omitted-and-filed-separately-with-the-commission", "type": "clause", "offset": [114, 162]}, {"key": "confidential-treatment", "type": "clause", "offset": [164, 186]}, {"key": "with-respect-to", "type": "clause", "offset": [206, 221]}], "samples": [{"hash": "7d11U59M8gb", "uri": "/contracts/7d11U59M8gb#interim-reports", "label": "Cooperative Research and Development Agreement (Introgen Therapeutics Inc)", "score": 18.0, "published": true}, {"hash": "6qrKAPofzFB", "uri": "/contracts/6qrKAPofzFB#interim-reports", "label": "Cooperative Research and Development Agreement (Introgen Therapeutics Inc)", "score": 18.0, "published": true}], "hash": "f9bc8fd8c9dfa86a1c1ca89048be5824", "id": 6}, {"size": 2, "snippet": "means the HY1 2015 Interim Report and the HY1 2016 Interim Report.", "snippet_links": [{"key": "interim-report", "type": "clause", "offset": [19, 33]}], "samples": [{"hash": "i95ktPUFWvy", "uri": "https://tryg.com/sites/tryg.com/files/reports_presentations/Tryg%20Forsikring,%20Tier%202%20Prospectus,%20bond%20issue,%20SEK_12-42785.pdf?icid=p_anmeldskade_loginpopup_erhverv", "label": "tryg.com", "score": 8.3429158111, "published": false}], "hash": "639f4b4f91d44013647cf3d6beb0e7b4", "id": 7}, {"size": 1, "snippet": "means the financial statements (including income statement, balance sheet and cash flow", "snippet_links": [{"key": "the-financial-statements", "type": "definition", "offset": [6, 30]}, {"key": "income-statement", "type": "clause", "offset": [42, 58]}, {"key": "balance-sheet", "type": "clause", "offset": [60, 73]}, {"key": "cash-flow", "type": "clause", "offset": [78, 87]}], "samples": [{"hash": "jZSguj7hVD6", "uri": "https://investor.silabs.com/static-files/c7678446-c535-45d9-9d9e-de731fcd3f6c", "label": "investor.silabs.com", "score": 9.9623545517, "published": false}], "hash": "898bbe0e9d9ecb8d26d714a3c57ea5dc", "id": 8}, {"size": 1, "snippet": "has the meaning ascribed thereto in Section 4.5(a) of this Agreement.", "snippet_links": [{"key": "this-agreement", "type": "clause", "offset": [54, 68]}], "samples": [{"hash": "6hTOQsqhhzA", "uri": "/contracts/6hTOQsqhhzA#interim-reports", "label": "Stock Purchase Agreement (Del Monte Foods Co)", "score": 21.0, "published": true}], "hash": "b11745fe3a17c731be22d409b12ca354", "id": 9}, {"size": 1, "snippet": "means the financial statements (including income statement, balance sheet and cash flow statement) of the Company for the period of 1 January 2014 through 31 December 2014 and enclosed as Appendix G.", "snippet_links": [{"key": "the-financial-statements", "type": "definition", "offset": [6, 30]}, {"key": "income-statement", "type": "clause", "offset": [42, 58]}, {"key": "balance-sheet", "type": "clause", "offset": [60, 73]}, {"key": "cash-flow-statement", "type": "definition", "offset": [78, 97]}, {"key": "of-the-company", "type": "clause", "offset": [99, 113]}, {"key": "period-of", "type": "clause", "offset": [122, 131]}, {"key": "december-2014", "type": "clause", "offset": [158, 171]}], "samples": [{"hash": "30ZgGrB3l6p", "uri": "/contracts/30ZgGrB3l6p#interim-reports", "label": "Sale and Purchase Agreement (Silicon Laboratories Inc)", "score": 24.0924024641, "published": true}], "hash": "1f0994a4ff919728cd89be45b3bdecc4", "id": 10}], "next_curs": "ClwSVmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjgLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIYaW50ZXJpbS1yZXBvcnRzIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"size": 35, "snippet": "has the meaning set forth in Section 5.1.9.", "title": "Interim Reports", "id": "interim-reports", "examples": ["<strong>Interim Reports</strong> are intended to supplement prior reports as needed for significant case developments.", "Pursuant to the Exchange Act, it submits such <strong>Interim Reports</strong> to the SEC on Reports on Form 6-K.", "Tenant shall prepare and deliver to Landlord, or shall cause Operator to prepare and deliver to Landlord during the term of the Operating Agreement, a copy of any and all <strong>Interim Reports</strong> or Annual Financial Reports (as such terms are defined in the Operating Agreement) prepared by Tenant or prepared by Operator, if applicable, in accordance with the terms of the Operating Agreement.", "During the term of the Operating Agreement, Tenant shall use commercially reasonable efforts to enforce the Operator&#x27;s obligations under the Operating Agreement to prepare any and all <strong>Interim Reports</strong> and Annual Financial Reports.", "Project <strong>Interim Reports</strong> support payment claims and are therefore to be presented to Switzerland with the corresponding Reimbursement Request.", "The Counterparty publishes <strong>Interim Reports</strong> for each of the first three quarters of its fiscal year, each containing unaudited interim financial statements for such quarter.", "Subsequent interim payments shall be paid no later than 30 days after the approval of Project <strong>Interim Reports</strong>.", "<strong>Interim Reports</strong> support payment claims and are therefore to be presented to Switzerland with the corresponding Reimbursement Request.", "Verification and approval of Interim Project Reports is conducted by the Programme Operator and will be based on information on incurred expenditure, financial status and project progress contained in the <strong>Interim Reports</strong>, and on additional information to be submitted together with the reports.", "During Negotiations, <strong>Interim Reports</strong> may be made to the Union Membership by its Representatives and to the Board and the Administration by it Representatives."], "related": [["interim-report", "Interim Report", "Interim Report"], ["sos-reports", "SOS Reports", "SOS Reports"], ["esdm-report", "ESDM Report", "ESDM Report"], ["glj-report", "GLJ Report", "GLJ Report"], ["interim-statements", "Interim Statements", "Interim Statements"]], "related_snippets": [], "updated": "2025-07-06T21:58:35+00:00"}, "json": true, "cursor": ""}}